Infectious Disease Control

P&G partners with Philippine Red Cross for COVID-19 Bakuna Buses in CALABARZON

MANILA, Philippines, Sept. 20, 2021 /PRNewswire/ -- Procter & Gamble (P&G) Philippines continues stepping up as a force for good by supporting the Philippine Red Cross (PRC) mission to assist in the government's national COVID-19 vaccination program.

2021-09-20 15:09 2870

Experts Call on World Leaders to Commit to a Global Plan of Attack on COVID at Summit

More Than 60 Leading Organizations Across Civil Society, Academia, Philanthropy, Health, and Social Enterprise Define a 6-Point Plan to End the Global COVID-19 Crisis SEATTLE, Sept. 20, 2021 /PRNewswire/ -- This week, hosted by the United States , world leaders will gather virtually for theGlobal...

2021-09-20 12:00 2451

New Zealand's Cancer Organisations Warn Of COVID Pandemic-led Drop In Cancer Being Diagnosed And Treated

* Growing concern that people are reluctant to see their doctor about troubling symptoms during current uncertain period. This follows last year's lockdown which saw a decline in diagnosis of cancer across Aotearoa.[1]  * Around 9,000 New Zealanders die of cancer every year.[2]  * New campai...

2021-09-20 06:00 2057

SARS-CoV-2, Influenza A inactivated by zinc-embedded nylon fabric

A paper published in ACS Applied Materials Interfaces details effectiveness, describes protocol for future testing HOUSTON, Sept. 18, 2021 /PRNewswire/ -- An international team of scientists and engineers from theUniversity of Cambridge, the Icahn School of Medicine at Mount Sinai, ResInnova Lab...

2021-09-18 04:53 5033

COVID-19 Scoop: Epoch-Making GoldenBiotech's Oral COVID-19 New Drug Trial Got Green Light from the FDA to Extend Recruiting Severe COVID-19 Patients

TAIPEI, Sept.16, 2021 /PRNewswire/ -- Golden Biotechnology Corp.(TPEx:4132) ("GoldenBiotech", GBC), a leading Taiwanese biopharmaceutical company, announces that its oral investigational new drug Antroquinonol (HOCENA®) has made headway withCOVID-19 treatment development in more broaden clinical ...

2021-09-16 18:05 2387

Key milestone: DHL delivers 1 billion COVID-19 vaccine doses

* 1 billion vaccine doses shipped to more than 160 countries in the fight against COVID-19 sinceDecember 2020 * Smooth management and execution of different supply chain set-ups * Planning essential to identify and prevent future health emergencies SINGAPORE, Sept. 16, 2021 /PRNewswire/ -- C...

2021-09-16 16:00 15999

Sputnik V Demonstrates 97.2% Efficacy And High Safety Profile Against COVID During The Vaccination Campaign In Belarus

MOSCOW, Sept. 15, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces the real world data of the Ministry of Health of theRepublic of Belarus on the Russian Sputnik V coronavirus vaccine confirming its high efficacy during the vaccination campai...

2021-09-15 16:00 1767

iGene Laboratory donates 25,000 SARS-CoV-2 PCR Kits to Indonesia

SINGAPORE, Sept. 15, 2021 /PRNewswire/ -- iGene Laboratory Pte. Ltd donates 25,000 SARS-CoV-2 PCR Kits toIndonesia to assist the government of the Republic ofIndonesia in managing the COVID-19 disease outbreak. The occasion was marked with a symbolic hand-over ceremony at the Republic of Indonesi...

2021-09-15 10:22 2847

Humanforce Releases Solution to Help Employers Manage COVID-19 Vaccination Policies

SYDNEY, Sept. 15, 2021 /PRNewswire/ -- As increasing vaccination rates become a primary path towards reopeningAustralia, local workers are indicating a preference to work in environments where their colleagues are vaccinated. To assist businesses in managing complex workplace vaccination issues,H...

2021-09-15 07:00 2610

Jemincare group has completed the Phase I clinical trial of its anti-SARS-CoV-2 neutralizing antibody JMB2002

SHANGHAI, Sept. 14, 2021 /PRNewswire/ -- Recently, Jemincare group has declared that it has completed phase I clinical trial of self-developed novel coronavirus specific neutralizing antibody (Project code: JMB2002). The clinical trial of JMB2002 was stated in January 2021. A single-center, rand...

2021-09-14 11:43 3896

Gates Foundation's Annual Goalkeepers Report Finds Stark Disparities in COVID-19 Impacts

New data reveals world stepped up to prevent worst-case scenarios from happening; spotlights need for long-term investments to ensure an equitable recovery and continued progress toward the Global Goals SEATTLE, Sept. 14, 2021 /PRNewswire/ -- The Bill & Melinda Gates Foundation today launched it...

2021-09-14 11:00 3196

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval

The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care Number of U.S. sites for the study has also been expanded RHB-107, a nov...

2021-09-13 19:00 6497

Winners of HK$1 million in prizes including a Tesla Model 3 in the Goodman #goodshot Vaccination Lucky Draw announced

Goodman attracted over one million entries to its HK$1 million #goodshot Vaccination Lucky Draw, helping drive a recent surge in the COVID-19 vaccination rate inHong Kong. HONG KONG, Sept. 10, 2021 /PRNewswire/ -- Thirty winners were today announced by Goodman on the#goodshot Lucky Draw website ...

2021-09-10 20:06 4923

3DMed Diagnostics Donates Medical Supplies to Support COVID-19 Fight in Cambodia

SHANGHAI, Sept. 10, 2021 /PRNewswire/ -- Shanghai-based biotechnology company, 3DMed Diagnostics, has donated anti-coronavirus medical appliances worth US$218,000 to Cambodia's Ministry of Health to support its campaign against COVID-19. A handover ceremony was held onFriday September 3 via video ...

2021-09-10 18:22 3516

Whiz Gambit now available across EMEA

HONG KONG, Sept. 10, 2021 /PRNewswire/ -- As the world navigating the new normal, effective cleaning and disinfection practices have never been more important. In response to the growing demand, Whiz Gambit, the 2-in-1 AI-powered cleaning and disinfection robotic solution, jointly launched by So...

2021-09-10 11:00 3303

DiaCarta Receives CE/IVD for its New COVID 19 Screening Test that Identifies Delta Plus and New Variants

PLEASANTON, Calif., Sept. 10, 2021 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can ...

2021-09-10 02:02 2781

Biokangtai: Recombinant COVID-19 Vaccine(Adenovirus Vector) licensed for manufacturing, which actively promotes vaccine export and improves vaccine accessibility

SHENZHEN, China, Sept. 8, 2021 /PRNewswire/ -- The other day Shenzhen Kangtai Biological Products Co., Ltd. announced that the company and AstraZeneca signed the "Amendment 1 to License Agreement". In addition to authorizing BIOKANGTAI to commercialize its Recombinant COVID-19 Vaccine(Adenovirus ...

2021-09-09 11:40 4128

Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza

-- First participants enrolled in Phase 1 clinical trial of combination NanoFlu™/NVX–CoV2373 vaccine with Matrix-M™ adjuvant -- Phase 1/2 study will evaluate immunogenicity and safety GAITHERSBURG, Md., Sept. 8, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated...

2021-09-08 20:30 5909

Bactiguard appoints new CEO

The Board of Bactiguard Holding AB (publ) has today appointed Anders Göransson as the new CEO. Anders has extensive experience from consulting within McKinsey and has held several senior positions in Amgen, most recently as Head of Innovation Europe. Anders will start his employment in Bactiguard...

2021-09-08 09:51 2833

Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID-19 exposure or vaccine administration

VANCOUVER, BC and SAN CRISTÓBAL DE LA LAGUNA, Spain, Sept. 7, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") is pleased to announce that the Scientific Advisor for its CoviDTH program,Yvelise Barrios, MD, PhD, and Clinical Immuno...

2021-09-07 20:00 6590
1 ... 26272829303132 ... 44

Week's Top Stories